Literature DB >> 23475127

Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents.

Naghmeh Zahra Mirhosseini1, Suzana Shahar, Majid Ghayour-Mobarhan, Abdullah Banihashem, Nor Azmi Kamaruddin, Mohammad Reza Hatef, Habib Alah Esmaili.   

Abstract

Thalassemia and the blood transfusion complications associated with it predispose children to poor bone health. This study was conducted to determine the prevalence of bone-related abnormalities and identify the bone health predictors within this population. One hundred and forty transfusion-dependent beta thalassemic subjects 8-18 years old in Mashhad, Iran, participated in this cross-sectional study. Anthropometric measures, dietary intake, bone-related biomarkers and bone densitometry, were assessed. The incidence of underweight and short stature was 33.6 and 41.4 %, respectively, which were indicators of malnutrition among thalassemic subjects in this study. Low bone density was detected in the lumbar spine and femoral region in 82 and 52 % of subjects, respectively. Hypocalcemia and hypophosphatemia were seen in 22 and 18.2 %, whilst vitamin D deficiency was present in more than 85 % of thalassemic children and adolescents. The relationships between weight, height and other anthropometric indices, serum calcium and bone markers, intake of macronutrients, zinc and vitamin E with bone mineral density (BMD) and bone mineral content (BMC) in the lumbar spine and femoral area were positively related, indicating that better nutritional status were associated with higher BMD and BMC values. Puberty, gender and serum osteocalcin were negative predictors for BMD and BMC values, whereas age, weight and height were the positive predictors. High incidence of low bone density and deficit in other aspects of bone health among thalassemia patients makes routine bone health assessment necessary for this vulnerable group. Considering influencing factors, dietary counseling and preventive supplementation therapy for this high risk group of children and adolescents may be necessary, although this should be assessed by intervention studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475127     DOI: 10.1007/s00774-013-0433-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  24 in total

Review 1.  Clinical review 117: Hormonal determinants and disorders of peak bone mass in children.

Authors:  L A Soyka; W P Fairfield; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents.

Authors:  Mir Reza Bekheirnia; Alireza Abdollah Shamshirsaz; Mohammad Kamgar; Navid Bouzari; Ghazaleh Erfanzadeh; Nima Pourzahedgilani; Seyed Mahmood Tabatabaie; Amirhooshang Abdollah Shamshirsaz; Masood Kimiagar; Fatemeh Ezzati; Bagher Larijani
Journal:  Biol Trace Elem Res       Date:  2004-03       Impact factor: 3.738

3.  Preliminary study of the effect of vitamin E supplementation on the antioxidant status of hemoglobin-E carriers.

Authors:  Attakorn Palasuwan; Suphan Soogarun; Viroj Wiwanitkit; Rataya Luechapudiporn; Paweena Pradniwat; Thamaporn Lertlum
Journal:  Southeast Asian J Trop Med Public Health       Date:  2006       Impact factor: 0.267

4.  Risk factors for low bone mineral density in children and young adults with Crohn's disease.

Authors:  E J Semeao; A F Jawad; N O Stouffer; B S Zemel; D A Piccoli; V A Stallings
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

5.  Unbalanced bone turnover in children with beta-thalassemia.

Authors:  Osama S Salama; Youssef A Al-Tonbary; Rania A Shahin; Omar A Sharaf Eldeen
Journal:  Hematology       Date:  2006-06       Impact factor: 2.269

6.  Treatment options for thalassemia patients with osteoporosis.

Authors:  Evangelos Terpos; Ersi Voskaridou
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

7.  Bone mineral density in beta - thalassemic Lebanese children.

Authors:  A Yazigi; G Maalouf; A Inati-Khoriati; H Tamim; C Saab
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-09       Impact factor: 2.041

8.  Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major.

Authors:  John C Wood; Susan Claster; Susan Carson; J D Menteer; Thomas Hofstra; Rachna Khanna; Thomas Coates
Journal:  Br J Haematol       Date:  2008-03-26       Impact factor: 6.998

9.  Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major.

Authors:  Azza A Tantawy; Mohamed El Kholy; Tarek Moustafa; Heba H Elsedfy
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

Review 10.  Dietary intake and bone status with aging.

Authors:  Katherine L Tucker
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  4 in total

1.  Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.

Authors:  M Bordbar; H Bozorgi; F Saki; S Haghpanah; M Karimi; A Bazrafshan; O R Zekavat
Journal:  J Endocrinol Invest       Date:  2019-06-21       Impact factor: 4.256

2.  Association of VDBP rs4701 Variant, but not VDR/RXR-α Over-Expression with Bone Mineral Density in Pediatric Well-Chelated β-Thalassemia Patients.

Authors:  Shaimaa Sahmoud; Mostafa S Ibrahim; Eman A Toraih; Noha Kamel; Manal S Fawzy; Samar Elfiky
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-07-01       Impact factor: 2.576

Review 3.  Vitamin D and bone health status in beta thalassemia patients-systematic review.

Authors:  P P Manolopoulos; G Lavranos; I Mamais; A Angouridis; K Giannakou; E O Johnson
Journal:  Osteoporos Int       Date:  2021-01-09       Impact factor: 4.507

4.  Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan.

Authors:  Sadia Sultan; Syed Mohammed Irfan; Syed Ijlal Ahmed
Journal:  Adv Hematol       Date:  2016-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.